Diego F. Calvisi

Also affiliated with University of Regensburg

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 34 papers. Top paper: “Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies”.

Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies

Hepatology(2020)10.1002/hep.31310

N/A

0DataRank · unranked

123 citations

Panagiotis Paliogiannis, Diego F. Calvisi, Xin Chen, Xinjun Lu

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

Gut(2020)10.1136/gutjnl-2020-320716

N/A

0DataRank · unranked

107 citations

Xinhua Song, Pan Wang, Yi Zhou, Xinjun Lu, Jingxiao Wang +10 more

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis

Cellular and Molecular Gastroenterology and Hepatology(2020)10.1016/j.jcmgh.2020.11.008

N/A

0DataRank · unranked

76 citations

Jingxiao Wang, Shanshan Zhang, Jiaoyuan Jia, Xianqiong Liu, Jie Zhang +12 more

The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans

American Journal Of Pathology(2020)10.1016/j.ajpath.2020.03.011

N/A

0DataRank · unranked

53 citations

Jie Zhang, Katja Evert, Xiaolei Li, Liu Pin, András Kiss +12 more

mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy

American Journal Of Pathology(2020)10.1016/j.ajpath.2019.12.010

N/A

0DataRank · unranked

18 citations

Haichuan Wang, Jingxiao Wang, Deviana Burhan, Runze Shang, Pan Wang +14 more

Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model

American Journal Of Pathology(2020)10.1016/j.ajpath.2020.03.010

N/A

0DataRank · unranked

9 citations

Meng Xu, Liu Pin, Bin-yong Liang, Manning Qian, Haichuan Wang +8 more

Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes‐Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans

Hepatology(2020)10.1002/hep.31692

N/A

0DataRank · unranked

39 citations

Xinhua Song, Haotian Liao, Pan Wang, Yi Zhang, Li Che +15 more

Oncogene-dependent function of BRG1 in hepatocarcinogenesis

Cell Death and Disease(2020)10.1038/s41419-020-2289-3

N/A

0DataRank · unranked

33 citations

Xinhua Song, Dan Cao, Kairong Cui, Jingxiao Wang, Kirsten Utpatel +8 more

CDK9 is dispensable for YAP‐driven hepatoblastoma development

Pediatric Blood & Cancer(2020)10.1002/pbc.28221

N/A

0DataRank · unranked

4 citations

András Kiss, Zsuzsa Schaff, Katja Evert, Yi Zhang, Sheng Zhong +5 more

Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation

Journal of Hepatology(2021)10.1016/j.jhep.2021.05.018

N/A

0DataRank · unranked

111 citations

Hongwei Xu, Pan Wang, Jingxiao Wang, Silvia Affò, Haichuan Wang +13 more

TAZ is indispensable for c-MYC-induced hepatocarcinogenesis

Journal of Hepatology(2021)10.1016/j.jhep.2021.08.021

N/A

0DataRank · unranked

95 citations

Shanshan Zhang, Yi Zhang, Jiaoyuan Jia, Jingxiao Wang, Xianqiong Liu +11 more

YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice

American Journal Of Pathology(2021)10.1016/j.ajpath.2021.05.017

N/A

0DataRank · unranked

59 citations

Baogang Peng, Ge Chen, Giovanni Mario Pes, Silvia Ribback, Cindy Ament +10 more

TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis

Journal of Hepatology(2021)10.1016/j.jhep.2021.01.044

N/A

0DataRank · unranked

58 citations

Yi Zhou, Manning Qian, Meng Xu, Jingxiao Wang, Yi Zhang +13 more

Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer

Gut(2021)10.1136/gutjnl-2021-325405

N/A

0DataRank · unranked

51 citations

Agnieszka Seretny, Lena Wendler, Ana Banito, Christoph Eckert, Kersten Breuer +16 more

Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice

American Journal Of Pathology(2021)10.1016/j.ajpath.2021.01.010

N/A

0DataRank · unranked

42 citations

Bin-yong Liang, Xinhua Song, Haichuan Wang, Matthias Evert, Yi Zhou +4 more

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models

Frontiers in Oncology(2021)10.3389/fonc.2021.756672

N/A

0DataRank · unranked

35 citations

Antonio Solinas, Diego F. Calvisi, Shanshan Deng

Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression

Cell Death and Disease(2021)10.1038/s41419-021-03488-z

N/A

0DataRank · unranked

33 citations

Pan Wang, Meng Xu, Xinhua Song, Hong Wu, Matthias Evert +4 more

Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma

Cell Death and Disease(2021)10.1038/s41419-021-04206-5

N/A

0DataRank · unranked

28 citations

Kefei Chen, Runze Shang, Xinyan Chen, Yi Zhang, Xinhua Song +6 more

Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development

Communications Biology(2021)10.1038/s42003-021-02286-9

N/A

0DataRank · unranked

16 citations

Gloria Scattolin, Patrizia Romani, Cindy Ament, Silvia Ribback, Xin Chen +4 more

β-Catenin signaling in hepatocellular carcinoma

Journal of Clinical Investigation(2022)10.1172/jci154515

N/A

0DataRank · unranked

290 citations

Zhong Xu, Yi Zhang, Matthias Evert, Diego F. Calvisi, Xin Chen +1 more

Therapeutic efficacy of FASN inhibition in preclinical models of HCC

Hepatology(2022)10.1002/hep.32359

N/A

0DataRank · unranked

126 citations

Yi Zhou, Hongwei Xu, Xue Wang, Yi Zhang, Runze Shang +9 more

β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma

Gastroenterology(2022)10.1053/j.gastro.2022.04.028

N/A

0DataRank · unranked

49 citations

Hongwei Xu, Guofei Cui, Bin-yong Liang, Xi Chen, Xiangzheng Chen +20 more

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02394-2

N/A

0DataRank · unranked

42 citations

Shanshan Zhang, Silvia Ribback, Sara Steinmann, Marcella Sini, Cindy Ament +17 more

Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation‐driven hepatocarcinogenesis

Hepatology(2022)10.1002/hep.32693

N/A

0DataRank · unranked

29 citations

Haichuan Wang, Yu Qiao, Xue Wang, Manning Qian, Xinhua Song +13 more

Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models

Journal of Clinical Investigation(2023)10.1172/jci163291

N/A

0DataRank · unranked

40 citations

Shanshan Deng, Jiejie Xu, Benjamin L. Green, Honghua Zhang, Guofei Cui +13 more

Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis

Cell Death and Disease(2023)10.1038/s41419-023-05958-y

N/A

0DataRank · unranked

22 citations

Guofei Cui, Hongwei Xu, Joanne Chun, Doris Yang, Zheng Zhang +8 more

Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges

Biomedicines(2024)10.3390/biomedicines12071624

N/A

0DataRank · unranked

23 citations

Weiting Liao, Giovanni Deiana, Davide Rizzo, Xin Chen, Diego F. Calvisi +1 more

TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M

Journal of Clinical Investigation(2024)10.1172/jci174415

N/A

0DataRank · unranked

12 citations

Shu Zhang, Guoteng Qiu, Xue Wang, Andrew Yonemura, Hongwei Xu +15 more

HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-03177-7

N/A

0DataRank · unranked

7 citations

Isabella Gigante, Marina Serra, Gianpaolo Vidili, Maria M. Simile, Sara Steinmann +15 more

MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma

Toxicological Sciences(2024)10.1093/toxsci/kfae126

N/A

0DataRank · unranked

3 citations

Ya Zhang, Jiahao Xue, Matthias Evert, Diego F. Calvisi, Xin Chen +2 more

High-fat diet-induced AKT-palmitoylation in hepatocellular carcinoma: a breakthrough mechanistic investigation

Gut(2024)10.1136/gutjnl-2023-331857

N/A

0DataRank · unranked

2 citations

Diego F. Calvisi, Wei Qiu, Claudia R. Keating

Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma

Cell Death and Disease(2024)10.1038/s41419-024-06839-8

N/A

0DataRank · unranked

2 citations

Xinjun Lu, Xue Wang, Binyong Liang, Hongwei Xu, Doris Yang +12 more

Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-1615

N/A

0DataRank · unranked

3 citations

Yi Zhou, Weiting Liao, Eleonora Cossu, Matthias Evert, Shu Zhang +19 more

Targeting mTORC2-dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET–activated and β-catenin–mutated hepatocellular carcinoma

Hepatology(2025)10.1097/hep.0000000000001637

N/A

0DataRank · unranked

2 citations

Yi Zhou, Shu Zhang, Christine Farrar, Xuemei Xie, Jian Li +18 more